SAINT PAUL, Minn.--(BUSINESS WIRE)--Syntiron (www.syntiron.com) today announced that it was named winner of the Biotechnology Award at the 2008 Tekne Awards in the small and growing company category. Syntiron was recognized for its ongoing development of human vaccines for the prevention of multiple bacterial pathogens, most notably, nosocomial infections (Staphylococcus aureus/MRSA), food and waterborne infections (Salmonella, E. coli, and Shigella), and bacterial biowarfare agents (Bacillus anthracis/anthrax, Yersinia pestis/plague, and Burkholderia pseudomallei/melioidosis).
